Navigation Links
Poniard Pharmaceuticals Presents Positive Survival Data from a Phase 2 Clinical Study of Picoplatin in Metastatic Prostate Cancer at the 2010 American Society of Clinical Oncology Genitourinary Cancers Symposium
Date:3/5/2010

SOUTH SAN FRANCISCO, Calif., March 5 /PRNewswire-FirstCall/ -- Poniard Pharmaceuticals, Inc. (Nasdaq: PARD), a biopharmaceutical company focused on innovative oncology therapies, today announced the presentation of positive final data, including survival data, from the Company's Phase 2 clinical trial of picoplatin as a first-line therapy in men with metastatic castration-resistant (hormone-refractory) prostate cancer (CRPC).  The results were presented in a General Poster Session today at the 2010 American Society of Clinical Oncology's Genitourinary Cancers Symposium in San Francisco, CA.

The final data showed that picoplatin, in combination with docetaxel and prednisone, the current standard of care for CRPC, produced a clinically meaningful benefit in patients as measured by overall survival, progression-fr
'/>"/>

SOURCE Poniard Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine news :

1. Poniard Pharmaceuticals to Host Conference Call and Webcast at 8:00 a.m. Eastern Time Tomorrow to Discuss Results of Pivotal Phase 3 SPEAR Trial in Small Cell Lung Cancer
2. Poniard Pharmaceuticals to Present at Two Upcoming Investor Conferences in August
3. Poniard Pharmaceuticals Announces Positive Efficacy and Safety Data From Phase 2 Clinical Trial of Picoplatin in Men With Metastatic Prostate Cancer
4. Poniard Pharmaceuticals Presents Final Results of Phase 1 Study of Oral Picoplatin Demonstrating Bioavailability
5. Poniard Announces Publication of Results of Picoplatin Phase 2 Study in Journal of Clinical Oncology
6. Poniard Pharmaceuticals to Focus Company Resources on Late-Stage Oncology Candidate Picoplatin Through Realignment of Research Organization
7. Poniard Pharmaceuticals to Present at Needham & Companys Cancer Therapeutics: Today & Tomorrow Conference
8. Poniard Pharmaceuticals Receives Going Concern Qualification
9. Poniard Pharmaceuticals Announces Appointment of Greg Weaver as Chief Financial Officer
10. Poniard Pharmaceuticals Provides 2009 Clinical Data Goals for Picoplatin
11. Poniard Pharmaceuticals Reports Third Quarter 2008 Financial Results and Corporate Update
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... Date: Thursday, June 4, 2015 , Time: 2 ... Broad Street, 4th floor, Philadelphia, Pa 19107 , ... will visit Philadelphia City Council to urge city leaders ... C in Philadelphia’s at-risk populations. , Foundation leaders and ... B United Philadelphia (HBUP), will join Hepatitis C Allies ...
(Date:6/2/2015)... New York, NY (PRWEB) June 02, 2015 ... leader in minimally invasive spine surgery with three locations ... office in New York City. The new facility is ... York, N.Y. 10028. Telephone consultations and appointments can be ... founder and chief surgeon at Atlantic Spine Center, has ...
(Date:6/2/2015)... (PRWEB) June 02, 2015 Pacifica ... fund set up by current and former students to ... beloved faculty member from 2002 until his death in ... intelligence, and depth of feeling, as well as his ... His capacities as an analyst, teacher, and writer were ...
(Date:6/1/2015)... The National Association of Professional Women ... 2015-2016 inductee into its VIP Woman of the Year ... leadership in business. NAPW is the nation’s leading networking ... members and over 200 operating Local Chapters. , “I’m ... NAPW President Star Jones. “Job satisfaction is essential for ...
(Date:6/1/2015)... 02, 2015 The National Association ... as a 2015-2016 inductee into the NAPW VIP ... with this prestigious distinction for leadership in academics. With ... Chapters, NAPW is the nation’s leading networking organization exclusively ... with this important distinction,” said NAPW President Star Jones. ...
Breaking Medicine News(10 mins):Health News:Hepatitis B Foundation to Urge Philadelphia Leaders to Make Viral Hepatitis Prevention a Local Priority 2Health News:Renowned Endoscopic Spine Surgeon Dr. Kaixuan Liu Announces Opening of Park Avenue Office 2Health News:Pacifica Graduate Institute - Mythological Studies Students Establish Memorial Scholarship to Honor Dr. V. Walter Odajnyk 2Health News:Pacifica Graduate Institute - Mythological Studies Students Establish Memorial Scholarship to Honor Dr. V. Walter Odajnyk 3Health News:National Association of Professional Women Inducts Miriam Wirski, Holistic Life Coach, Into its VIP Woman of the Year Circle 2Health News:National Association of Professional Women Inducts Marcia Ditmyer, Vice President of Academy for Academic Leadership, Into its VIP Professional Woman of the Year Circle 2
... , INDIANAPOLIS, Sept. 9 WellPoint, Inc. (NYSE: ... Medicare Advantage and 2010 Medicare Part D health benefit plans effective Oct. ... Medicare Part D health benefit plans on Nov. 15, 2009 for the ... Medicare and Medicaid Services (CMS) has determined that WellPoint has corrected deficiencies ...
... approval of second HPV vaccine, Cervarix, to prevent cervical cancer ... recommended Wednesday that use of the vaccine Gardasil, already administered ... help prevent genital warts in young males. , A U.S. ... expanded use of the vaccine for males 9 to 26. ...
... , WASHINGTON, Sept. 9 San Francisco Mayor ... tonight for the President,s historic speech on healthcare reform before a ... As Co-Chair of the U.S. Conference of Mayors Healthcare ... mayors around the country to urge Congress to pass comprehensive health ...
... dormant, common virus that crosses over into brain , WEDNESDAY, ... of the reason why Tysabri, a drug used to treat ... but potentially deadly brain disease in some patients. , The ... its slumber, allowing it to cross into the brain. , ...
... Sept. 9 Stryker Corporation (NYSE: SYK ) announced ... 20, 2009, at 4:30 p.m., Eastern Time, to discuss the Company,s ... an operational update. Operating results for the quarter ended September 30, ... , To participate in the conference call dial 800-706-7745 ...
... , PITTSBURGH, Sept. 9 The California ... host filmmaker Michael Moore at a special reception Monday night, along ... A Love Story" at the AFL-CIO national convention in Pittsburgh. , ... will outline the ongoing campaign for single payer healthcare reform by ...
Cached Medicine News:Health News:Statement on WellPoint's Re-Entry into Medicare Market 2Health News:FDA Panel Backs Giving HPV Vaccine Gardasil to Young Males 2Health News:FDA Panel Backs Giving HPV Vaccine Gardasil to Young Males 3Health News:FDA Panel Backs Giving HPV Vaccine Gardasil to Young Males 4Health News:Mayor Gavin Newsom to Be President Obama's Guest for Healthcare Reform Speech to the Nation 2Health News:Scientists Find Clue to Dangerous Side Effect of MS Drug 2Health News:Scientists Find Clue to Dangerous Side Effect of MS Drug 3Health News:Stryker To Host Conference Call on October 20, 2009 2Health News:Nurses, AFL-CIO Unions to Host Michael Moore and Special Screening of New Film at AFL-CIO Convention 2
(Date:6/1/2015)... DUBLIN , May 29, 2015 ... the addition of the "Global A Dialyzer ... 2014" report to their offering. ... Reprocessor ) Industry Report 2014 is a professional ... the A dialyzer reprocessing machine industry. The ...
(Date:6/1/2015)... N.Y. , June 1, 2015 ... HRTX ) today announced positive, top-line results ... MAGIC evaluated the efficacy and safety of the ... SUSTOL ® (granisetron injection, extended release) as ... (IV) neurokinin-1 (NK 1 ) receptor antagonist fosaprepitant ...
(Date:6/1/2015)... CLEVELAND , June 1, 2015 Researchers ... and Case Western Reserve University School of Medicine will ... evaluating a potential novel combination treatment for cancer patients ... gene mutations in small cell lung cancer (SCLC), at ... (ASCO) Annual Meeting in Chicago . ...
Breaking Medicine Technology:Global A Dialyzer Reprocessing Machine (A Dialyzer Reprocessor) Industry Report 2014 - Development Trends Forecasts to 2020 2Global A Dialyzer Reprocessing Machine (A Dialyzer Reprocessor) Industry Report 2014 - Development Trends Forecasts to 2020 3New cancer therapy study results - MAGIC Trial 2UH Case Medical Center Experts to Present Data at 51st ASCO Annual Meeting 2UH Case Medical Center Experts to Present Data at 51st ASCO Annual Meeting 3
... 2011 eCardio Diagnostics ( www.ecardio.com ) announced today ... an exclusive ranking of the nation,s fastest-growing private companies. ... #912 overall and #65 in the Health segment this ... The list represents the most comprehensive look at ...
... 24, 2011 "Production of Propofol was stopped after the ... Eglet attorney for the plaintiffs. In a stunning turn in ... Robert Eglet told the jury that production of the sedative ... million verdict in the Chanin trial in May 2010. Teva ...
Cached Medicine Technology:Inc. Magazine Unveils Its Annual Exclusive List of America's Fastest-Growing Private Companies—the Inc. 500|5000 22nd Day of Testimony: Mainor Eglet Attorney Continues Questioning Teva Pharmaceuticals Vice President 2
... German Craftsmanship have produced ... in the world. Ocutek® ... to you! Only holders ... certificate, which requires and ...
... Centuries of German Craftsmanship ... surgical instrumentation in the ... them available to you! ... coveted Meisterbrief certificate, which ...
... Centuries of German Craftsmanship ... surgical instrumentation in the ... them available to you! ... coveted Meisterbrief certificate, which ...
... Centuries of German Craftsmanship ... surgical instrumentation in the ... them available to you! ... coveted Meisterbrief certificate, which ...
Medicine Products: